CONTEMPORARY DRUG PROBLEMS is a distinguished academic journal published by SAGE PUBLICATIONS INC, focusing on critical issues within the realms of drug policy, health advocacy, and law. With a legacy dating back to its inception in 1973 and a noticeable convergence in subsequent years, the journal serves as a vital forum for researchers, practitioners, and policymakers engaged in understanding the multifaceted challenges related to drug use and its societal impacts. Holding an impressive Q2 ranking in both Health Policy and Health (social science), and a Q1 distinction in Law, the journal positions itself as an essential resource for advancing knowledge and fostering dialogue in these essential fields. Although it operates under traditional access models, its wide-ranging insights make it indispensable for those who aim to contribute meaningfully to the discourse surrounding contemporary drug issues. With its robust Scopus rankings, including a significant 89th percentile in Social Sciences Law, CONTEMPORARY DRUG PROBLEMS remains a pivotal source for scholars and professionals alike, striving to address and mitigate the complexities of drug-related problems on both a legal and social front.

International Journal of Drug Policy, published by Elsevier, stands as a crucial scholarly platform dedicated to advancing the field of drug policy research. With an impactful focus on health policy and medicine, this journal holds a prestigious Q1 ranking in both Health Policy and Medicine (miscellaneous) categories as of 2023, reflecting its high-quality contributions to the discourse surrounding drug use, regulation, and public health. Spanning publication from 1998 to 2024, the journal's rich archive of research serves as an essential resource for researchers, professionals, and students alike. While the journal is not open access, it provides invaluable insights and significant findings that drive policy-making decisions and foster evidence-based practices in drug management and health interventions. With a Scopus rank of #28 out of 310 in Health Policy and #55 out of 398 in Medicine (miscellaneous), the International Journal of Drug Policy is indispensable for those committed to exploring and understanding the complexities of drug-related issues on a global scale.

Sociology of Health & Illness is a leading academic journal published by Wiley, dedicated to exploring the intricate relationships between health, illness, and society. With an ISSN of 0141-9889 and an e-ISSN of 1467-9566, this journal has established a significant presence since its inception in 1979, continuing to provide valuable insights through to 2024. Recognized in the Q1 quartile across multiple categories, including Health Policy, Health (Social Science), and Public Health, Environmental and Occupational Health, it ranks impressively at 52nd in Social Sciences and holds a robust reputation with a Scopus classification that places it within the top percentiles of its field. The journal’s objectives focus on publishing high-quality research that advances understanding of the social determinants of health and their implications, making it indispensable for scholars, professionals, and students committed to health-related research. Operating from its headquarters in the United Kingdom, **Sociology of Health & Illness** contributes significantly to the global discourse on health and social welfare, reinforcing its vital role in shaping knowledge and policy in health and social sciences.

Ars Pharmaceutica is a distinguished open-access journal published by UNIV GRANADA, EDITORIAL, that has been at the forefront of pharmaceutical sciences since its establishment. With ISSN 0004-2927 and E-ISSN 2340-9894, this journal aims to disseminate high-quality research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of the field. With a historical scope that spans from 1980 to 2017, it has played a pivotal role in shaping the discourse surrounding pharmaceutical science and its intersection with the arts and humanities. Although currently ranked within the 13th percentile in Scopus for Pharmaceutical Science and the 11th percentile for History and Philosophy of Science, Ars Pharmaceutica continues to uphold its commitment to academic excellence and innovation. By providing a platform for open-access research, it encourages collaboration and knowledge sharing among researchers, professionals, and students, thus enhancing the broader understanding of pharmaceutical developments and their societal implications.

Welcome to the International Journal of Alcohol and Drug Research, an esteemed publication dedicated to advancing the understanding and research surrounding alcohol and drug-related issues. Published by Ohio State University, College of Social Work, this journal serves as a vital resource for professionals and scholars engaged in social sciences, public health, and epidemiological studies. Established as an Open Access journal since 2012, it ensures that valuable research findings are readily accessible to all, promoting awareness and disseminating knowledge critical in the fight against substance abuse. With a commendable impact in the field, the journal occupies a notable position in Scopus rankings, showcasing its contribution to social health, public health, and epidemiology. Covering an extensive scope with a commitment to rigorous research, the journal aims to foster collaboration between researchers, policymakers, and practitioners, ultimately driving innovative solutions and best practices in the realm of alcohol and drug research.

Psicodebate-Psicologia Cultura y Sociedad is a distinguished journal dedicated to the dissemination of research in the fields of psychology, culture, and society. Published by UNIV PALERMO, this journal has embraced the principles of Open Access since 2001, making its high-quality content freely available to a global audience. Based in Buenos Aires, Argentina, this journal fosters a vibrant academic environment by encouraging interdisciplinary dialogue and innovative research approaches. With a keen focus on the intricate relationships between psychological theory and cultural practices, Psicodebate serves as a crucial platform for researchers, professionals, and students alike, contributing significantly to the understanding of contemporary social issues and cultural phenomena. The commitment to accessibility and scholarly excellence affirms its importance in the academic landscape, making it a vital resource for those engaged in the study of human behavior and societal dynamics.

JOURNAL OF PSYCHOACTIVE DRUGS, published by Routledge Journals, Taylor & Francis Ltd, stands as a leading resource in the fields of psychology and medicine, focusing on the intersection of psychoactive substances and their impact on human behavior. With an ISSN of 0279-1072 and E-ISSN 2159-9777, this esteemed journal has been a pivotal platform for rigorous research since its inception in 1967, contributing to the understanding of drug use, its societal implications, and therapeutic potentials. It currently holds a Q2 ranking in both the miscellaneous categories of Medicine and Psychology for 2023, reflecting its significant standing within academic circles. Moreover, its Scopus rankings place it at the 49th percentile in General Psychology and 101st in Medicine, underscoring its relevance in contemporary research. Although it is not available via Open Access, the journal maintains a commitment to advancing knowledge through its annual publications until 2024. JOURNAL OF PSYCHOACTIVE DRUGS is essential for researchers, professionals, and students seeking to explore the complexities of psychoactive substances and their effects in various contexts.

Drugs Habits and Social Policy is an esteemed academic journal published by Emerald Group Publishing Ltd that focuses on the intersection of drug habits and the evolving landscape of social policy. With an ISSN of 2752-6739 and E-ISSN of 2752-6747, this journal contributes significantly to the fields of Clinical Psychology, Health Policy, and Public Health, and is ranked in the Q3 category across multiple disciplines in the 2023 categorizations. Featuring research that spans from 2022 to 2024, the journal provides a platform for critical insights and evidence-based discussions that are essential for understanding the social implications of drug use. Despite its current quartile ranking, the journal aims to elevate discourse among researchers, professionals, and students alike, reinforcing its commitment to impactful scholarship that can inform policy and practice. The journal is based in the United Kingdom, with its operations housed at Floor 5, Northspring 21-23 Wellington Street, Leeds, W YORKSHIRE LS1 4DL, ENGLAND. As a pivotal resource in its field, Drugs Habits and Social Policy invites contributions that can shape the future of health policy and improve societal outcomes.

Cultura y Religión is a pioneering academic journal dedicated to exploring the intersections of culture and religion within various socio-cultural contexts. Published by the Universidad Arturo Prat's Instituto de Estudios Indígenas, this journal has been an invaluable resource for researchers, professionals, and students since its inception, adopting an Open Access model since 2007 to enhance the dissemination of knowledge. With an ISSN of 0718-5472 and an E-ISSN of 0718-4727, this journal aims to provide a multidisciplinary platform for the examination of religious practices, beliefs, and their cultural implications, particularly in indigenous contexts. Situated in Iquique, Tarapacá, Chile, Cultura y Religión plays a critical role in enriching the academic discourse and fostering a deeper understanding of the cultural dimensions of religion, making it a must-read for those invested in cultural studies, anthropology, and religious studies.

Welcome to the Harm Reduction Journal, a premier academic platform published by BMC, dedicated to advancing the field of harm reduction since its inception in 2004. With an impressive track record as an Open Access publication, this journal addresses critical topics within the broad scope of medicine, psychiatry, and public health, making it indispensable for researchers, healthcare professionals, and students alike. As of 2023, it proudly holds a Q1 ranking in prestigious categories including Medicine (Miscellaneous), Psychiatry and Mental Health, and Public Health, Environmental and Occupational Health, reflecting its high impact and significance in the academic community. The journal is notable for its comprehensive discussions on innovative harm reduction strategies, public policy considerations, and evidence-based practice, fostering collaboration and knowledge exchange. With a global reach and commitment to enhancing health outcomes, the Harm Reduction Journal serves as a vital resource in the ever-evolving landscape of public health and addiction research.